(S1(S(SBAR(WHADVP(WRB When))(S(VP(VBN administered)(ADVP(RB concurrently)))))(, ,)(S(NP(DT the)(VBG following)(NNS drugs))(VP(MD may)(VP(VB interact)(PP(IN with)(NP(NNP Entity1))))))(: :)(UCP(NP(NNP Entity2))(: :)(S(VP(MD may)(VP(VB enhance)(NP(NP(DT the)(NN potential))(PP(IN for)(NP(NP(JJ renal)(NN toxicity))(, ,)(NP(NN bronchospasm))(CC and)(NP(NN hypotension)))))))))(. .)))